- ·The complete investor list: 12 names
- ·Watch Ribo Life Science: the Monday email on marks, rounds and moves
Ribo Life Science funding history
No funding rounds for Ribo Life Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ribo Life Science valuation
Ribo Life Science is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.2 billion (Jan 2026). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
How Ribo Life Science's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ribo Life Science, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Ribo Life Science
- What is Ribo Life Science worth?
- Ribo Life Science's last known valuation is $1.2B.
- How much has Ribo Life Science raised?
- Ribo Life Science has raised $285.3M in total funding across its recorded rounds.